DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,104 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $284,398 | -0.5% | 1,138 | -0.6% | 0.17% | -2.9% |
| Q1 2024 | $285,873 | +7.8% | 1,145 | +0.1% | 0.17% | -2.8% |
| Q4 2023 | $265,087 | -10.5% | 1,144 | -4.2% | 0.18% | -17.6% |
| Q3 2023 | $296,118 | +4.6% | 1,194 | +1.2% | 0.22% | +5.4% |
| Q2 2023 | $283,207 | -10.1% | 1,180 | -5.6% | 0.20% | -16.0% |
| Q1 2023 | $314,985 | -2.2% | 1,250 | +0.2% | 0.24% | -7.6% |
| Q3 2022 | $322,000 | +2.5% | 1,247 | +0.6% | 0.26% | +11.9% |
| Q2 2022 | $314,000 | -13.5% | 1,240 | +0.1% | 0.24% | +9.3% |
| Q1 2022 | $363,000 | +30.1% | 1,239 | +46.3% | 0.22% | +36.7% |
| Q4 2021 | $279,000 | +20.8% | 847 | +11.6% | 0.16% | +1.9% |
| Q3 2021 | $231,000 | -9.4% | 759 | -47.4% | 0.16% | -18.8% |
| Q2 2020 | $255,000 | -2.3% | 1,443 | -23.4% | 0.19% | -18.7% |
| Q1 2020 | $261,000 | -9.4% | 1,885 | +0.5% | 0.24% | +43.3% |
| Q4 2019 | $288,000 | +9.5% | 1,876 | +3.0% | 0.16% | +3.8% |
| Q3 2019 | $263,000 | +1.2% | 1,821 | 0.0% | 0.16% | +1.9% |
| Q2 2019 | $260,000 | +3.2% | 1,821 | -4.5% | 0.16% | +0.6% |
| Q1 2019 | $252,000 | – | 1,907 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |